Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium Aug 28, 2023
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update Aug 11, 2023
Ocuphire Pharma to Present at the Canaccord 43rd Annual Growth Conference and the H.C. Wainwright Ophthalmology Conference in August Aug 8, 2023
Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit Jul 26, 2023
Ocuphire Presents APX3330 ZETA-1 Clinical Data in Late-Breaker Session at the American Diabetes Association’s Annual Conference Jun 27, 2023
Ocuphire Announces Late Breaking Presentation on APX3330 ZETA-1 Clinical Data at American Diabetes Association Annual Conference Jun 21, 2023
